PTCT vs TOST · rev $633.1M vs P/E 161, rev $3.54B
PTC Therapeutics Inc (PTCT) versus Toast Inc (TOST) — a side-by-side from cached financials, not a winner call.
PTC Therapeutics Inc (PTCT) is a biotechnology company listed on NASDAQ.
Toast Inc (TOST) is a software - infrastructure company listed on US.
Latest reported PTCT revenue for 2026-06-30 was $633.1M. Net income was $80.7M. PTCT currently screens at market cap $6.51B.
Latest reported TOST revenue for 2026-06-30 was $3.54B. Net income was $280.0M. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
PTCT currently screens at market cap $6.51B. TOST currently screens at market cap $25.21B and trailing P/E 161.4.
Not investment advice. Open the PTCT and TOST stock pages for the full models.
Not investment advice.